BIOMAT Database Logo BIOMAT Database Logo

Sequential IL-2 and IL-2R levels predict rejection in liver allograft recipients. 1991

M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D015375 Receptors, Interleukin-2 Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN. IL-2 Receptors,Interleukin-2 Receptor,Interleukin-2 Receptors,Receptors, IL-2,Receptors, T-Cell Growth Factor,T-Cell Growth Factor Receptors,IL-2 Receptor,IL2 Receptor,IL2 Receptors,Interleukin 2 Receptor,Receptor, TCGF,T-Cell Growth Factor Receptor,TCGF Receptor,TCGF Receptors,IL 2 Receptor,IL 2 Receptors,Interleukin 2 Receptors,Receptor, IL-2,Receptor, IL2,Receptor, Interleukin 2,Receptor, Interleukin-2,Receptors, IL 2,Receptors, IL2,Receptors, Interleukin 2,Receptors, T Cell Growth Factor,Receptors, TCGF,T Cell Growth Factor Receptor,T Cell Growth Factor Receptors
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
Origin of elevated IL-2 and IL-2R in the urine of rejecting renal allograft recipients.
February 1989, Transplantation proceedings,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.
April 1994, Transplantation,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
[The level of IL-2 and IL-6 in stimulated peripheral lymphocyte supernatants of kidney transplant recipients can predict acute renal allograft rejection].
August 2017, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients.
June 1988, Transplantation proceedings,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
The cost of rejection in liver allograft recipients.
June 1998, Transplantation proceedings,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
Late acute rejection occurring in liver allograft recipients.
October 1996, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
[Predictive value of IL-2R in renal tissue during acute renal allograft rejection].
February 1997, Zhonghua wai ke za zhi [Chinese journal of surgery],
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients.
August 1990, Transplantation proceedings,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.
December 1996, Transplantation proceedings,
M A Simpson, and T Young-Fadok, and P N Madras, and R B Freeman, and R A Dempsey, and R L Jenkins, and A P Monaco
Soluble interleukin 2 receptor level in liver allograft recipients: an indicator of rejection.
February 1989, Transplantation proceedings,
Copied contents to your clipboard!